Cooper Research and Development Expenses 2010-2024 | COO

Cooper research and development expenses for the twelve months ending October 31, 2024 were $0.155B, a 12.88% increase year-over-year.

  • Cooper annual research and development expenses for 2024 were $0.155B, a 12.88% increase from 2023.
  • Cooper annual research and development expenses for 2023 were $0.137B, a 24.57% increase from 2022.
  • Cooper annual research and development expenses for 2022 were $0.11B, a 18.99% increase from 2021.

Cooper Research and Development Expenses 2010-2024 | COO

  • Cooper annual research and development expenses for 2024 were $0.155B, a 12.88% increase from 2023.
  • Cooper annual research and development expenses for 2023 were $0.137B, a 24.57% increase from 2022.
  • Cooper annual research and development expenses for 2022 were $0.11B, a 18.99% increase from 2021.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$75.2B
Becton Dickinson (BDX)$68.8B
Cardinal Health (CAH)$30.6B
West Pharmaceutical Services (WST)$24.4B
Labcorp (LH)$20B
Align Technology (ALGN)$16.7B
Henry Schein (HSIC)$9.1B
Merit Medical Systems (MMSI)$6B
DENTSPLY SIRONA (XRAY)$3.7B
Patterson (PDCO)$2.7B
CONMED (CNMD)$2.1B
STAAR Surgical (STAA)$1.1B
Lifevantage (LFVN)$317M
Pro-Dex (PDEX)$145M